- 更多网络例句与血管形成相关的网络例句 [注：此内容来源于网络，仅供参考]
-
Antibodies against col Ⅲ reacted strongly in the entire pterygial stroma. Conclusions Components of ECM are changed in the pterygium: the sub-epithelial connective tissues and vessels are more prominent in the pterygia than in normal conjunctiva tissues, and abnormal fibers are visible only in the deeper subepithelial connective tissues. This study documents the overexpression of LN and col Ⅲ. They may play roles in cellular adherency, migration and angiogenesis. Also this study documents the overexpression of MMP3 which may degrade ECM in the pathogenesis of the pterygium.
结论翼状胬肉组织中ECM的成分较正常球结膜发生改变，有大量的弹性纤维变性、胶原纤维增生及新生血管形成；col Ⅲ在翼状胬肉组织中表达增加，LN及胶原纤维可能对翼状胬肉中血管形成、细胞粘附和迁移及ECM重建起作用；MMP-3在翼状胬肉组织中表达增加，其对ECM成分的降解作用可能有助于翼状胬肉的形成和向角膜中央侵袭。
-
Angiogenesie and vasculogenesis comprise the mechanisms that responsible for the development of new blood vessels. Vasculogenesis is the process of in situ formation of blood vessels from endothelial progenitor cells or angioblast. Angiogenesis involves extension of the already formed primitive vasculature by the sprouting of new capillaries through migration and proliferation of previously differentiated ECs.
新血管形成的机制有血管生成和血管新生，前者是血管内皮前体细胞或成血管母细胞在原位分化为内皮细胞并形成血管的过程，后者则是已经分化的成熟内皮细胞移行并增生使原有血管延伸。
-
It has been suggested that VEGF is an important angiogenic factor in many physiological and pathological conditions.
在这些血管形成因子中，VEGF被认为是最重要的血管形成因子，参与了许多生理和病理性血管形成。
-
He findings of TRAFFIC provide evidence of clinical therapeutic angiogenesis by intra-arterial infusion of an angiogenic protein.
RAFFIC的研究发现，为临床血管内注射血管形成蛋白，从而治疗性的促进血管形成提供了证据。
-
VEGF can specifically increase the dividing, proliferation and movement of endotheliocyte, as well as the permeability of tumor vessels, making it a crucial angiogenic factor in research.
血管的生成机制中，血管内皮生长因子(vascular endothelial growth factor，VEGF)是重要的直接作用于血管内皮细胞的生长因子，可以特异性地促进内皮细胞分裂、增殖、移动，增加血管的通透性，在血管形成中起重要作用，是目前特别受重视的血管生成因子之一。
-
The mesenchyma stem cell is the multi-potential stem cell, and become the important seed cells in skin tissue engineering due to its unique biology characteristics.
组织工程化皮肤的血管构建技术涉及多个方面，如接种血管形成的种子细胞，进而促进血管结构的形成。
-
It appears to play an important role in both vasculogenesis and angiogenesis.
血管内皮生长因子是血管特异性生长因子，能特异性地作用于血管内皮细胞，诱导血管生成，在血管发生和血管形成过程中起重要作用。
-
Vascular endothelial growth factor has also been termed vascular-specific growth factor that is specific for the vascular endothelium. It appears to play an important role in both vasculogenesis and angiogenesis.
血管内皮生长因子是血管特异性生长因子，能特异性地作用于血管内皮细胞，诱导血管生成，在血管发生和血管形成过程中起重要作用。
-
Between women with or without endometriosis, the expression of VEGFmRNA of eutopic endometrium in the secretoiy phase was significantly higher than that in the proliferative phase(P.05). eutopic endometrium of women with endometriosis both in the proliferative phase and secretoiy phase expressed higher level VEGFmRNA than that in control group(P.05). Conclusion:①The expression of VEGF is adjusted by female'hormone.②VEGF is a very important factor that may contribute to the pathegenesis of endometriosis by promoting neovascularization,explanting of ectopic endometrium , increasing activity of angiopoiesis in eutopic endometrium③VEGF is a efficient organism maker to reflect invading growth, prognosis and metastasis potency of EMs.④VEGF may paly an important role in both pathogenesis and progress of endometriosis.
EM 患者VEGF 水平受女性性激素周期性调节；VEGF 是导致EM 发生特别是在位内膜血管活性增强、异位内膜种植、新生血管形成的重要机制，提示血管生成是EMs 发生中的一个重要因素；VEGF 可能不仅参与EM 的形成，并与进一步发展存在关系，提示血管生成在异位子宫内膜的种植、浸润中可能起着重要的病理生理作用，是EM 发病的必要环节；VEGF 是反映EM 侵袭生长、转移潜能、预后的有效生物指标，提示通过使用抗血管生成药物或抗血管生长因子抗体，来阻断血管生成，极有可能成为EM 在现有药物和手术治疗基础上的一种有效治疗策略和靶点。
-
Researches show that the disorder of the balance between the promotion factor and the inhibition factor of neovascularization is an important mechanism of the neovascularization. Suppressing the new blood vessel proliferation have already become the new target spot to treat this kind of disease.
研究发现新生血管形成因子与抑制因子之间的平衡失调是新生血管形成的重要机制，抑制血管增生已经成为治疗这类疾病的新靶点。
- 更多网络解释与血管形成相关的网络解释 [注：此内容来源于网络，仅供参考]
-
ectopic endometrium：血管形成
子宫内膜细胞:Endometrium | 血管形成:Ectopic endometrium | 在位内膜:eutopic endometrium
-
vascularization：血管形成
vascular wall 维管壁 | vascularization 血管形成 | vaseline 矿脂
-
superficial vascularization：表层血管形成
superficial vapour velocity 表面的蒸气速度 | superficial vascularization 表层血管形成 | superficial vein 浅静脉
-
angiofibroma：血管线维肿
angioedema (血管性水腫,血管性浮腫) | angiofibroma (血管線維腫) | angiogenesis (血管新生,血管形成,血管発生)
-
angiogenesis factor：血管生成因子
即需再生成新血管.新血管形成必需将附近原有的组织基质破坏,开辟出空间容许新血管生长,同时新生血管需与原先循环接通,在人体发现此些过程之完成有赖血管生成因子(angiogenesis factor)及基质蛋白酵素(matrix metalloproteinases)的存在,
-
Angiospastic constitution：血管痉挛性体质
Angioplastic sarcoma 血管形成性肉瘤 | Angiospastic constitution 血管痉挛性体质 | Angiospastic type 血管痉挛型
-
arteriogenesis：(動脈形成)
近期研究表明Ang1和VEGF共同基因转染能够更好促进缺血心肌的动脉形成(arteriogenesis)和血管形成. 单纯VEGF 165或Ang1基因转染,仅能使缺血心肌毛细血管密度上升36%,如果二者协同转染,可使血管密度上升75倍(21).
-
vasculogenesis：血管发生
☆ 血管生成素和其受体信息通路对血管形成的调节作用 中华实验外科杂志2000年第17卷第3期 陈立波 杨镇 关键词:血管生成素 受体 通路 机体的血管形成有血管发生和血管生成2种方式,血管发生(vasculogenesis)是胚胎发育过程中成血管细胞形成原始血管的过程,
-
vasoformative：血管形成
血管舒放 vasodilator | 血管形成 vasoformative | 血管收缩的 vasohypertonic; vasoconstrictor
-
vasohypertonic; vasoconstrictor：血管收缩的
血管形成 vasoformative | 血管收缩的 vasohypertonic; vasoconstrictor | 血管舒放的 vasohypotonic; vasodilator